BlossomHill Therapeutics
2 clinical trials · Sponsor
◉ Watch BlossomHill Therapeutics
| Record | Firm | Date |
|---|---|---|
| A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (NCT06706076) | BlossomHill Therapeutics | 2025-01-09 |
| A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome (NCT06501196) | BlossomHill Therapeutics | 2024-06-19 |
Track BlossomHill Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.